XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Equity | 12 Months Ended
--- | ---
Dec. 31, 2019
Equity [Abstract] |
Equity | Note 11. Equity a. Share capital The Company’s issued share capital is composed of ordinary shares NIS 0.01 par value per share. Ordinary shares confer upon their holders the right to receive notice to participate and vote in general meetings of the Company, and the right to receive dividends if declared. The Company’s ordinary shares are traded in the United States on the Nasdaq Global Select Market under the ticker symbol “SSYS”. As of December 31, 2019 and 2018, there were 54,441 thousand ordinary shares and 53,881 thousand ordinary shares issued and outstanding, respectively. The increase in the outstanding and issued ordinary shares during 2019 was attributable to exercises of stock options and RSUs under the Company’s stock-based compensation plans. On January 1, 2020, the reserve pool under the 2012 plan was increased by 0.5 million shares. b. Stock-based compensation plans The Stratasys Ltd. 2012 Omnibus Equity Incentive Plan (the “2012 Plan”), which became effective upon closing of the Stratasys-Objet merger, provides for the grant of options, restricted shares, RSUs, PSUs and other share-based awards to the Company’s and its subsidiaries’ respective directors, employees, officers, consultants, and to any other person whose services are considered valuable to the Company or any of its affiliates. Under the 2012 plan, options, RSUs and PSUs generally have a contractual term of ten years from the grant date. Options granted become exercisable and RSUs are vested over the requisite service period, which is normally a four-year period beginning on the grant date, subject to continued service to the Company. PSUs are vested only upon the achievement of certain pre-determined performance metrics. Once the performance metrics are met, vesting of PSUs is subject to continued service to the Company over the requisite service period, which is normally a two-year to four-year period. As of December 31, 2019, 0.9 million shares were available for future equity awards under the 2012 plan. Stock options A summary of the stock option activity for the year ended December 31, 2019 is as follows:
|  |  |  |  | Weighted Average
|  | Number of Options |  | Exercise Price
Options outstanding as of December 31, 2018 |  | 2,551,743 |  |  | $ | 30.82
Exercised |  | (249,956 | ) |  |  | 20.54
Forfeited |  | (340,255 | ) |  |  | 36.43
Options outstanding as of December 31, 2019 |  | 1,961,532 |  |  | $ | 31.16
Options exercisable as of December 31, 2019 |  | 1,585,035 |  |  | $ | 33.73
F-32 Table of Contents STRATASYS LTD. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The following table summarizes information about stock options outstanding at December 31, 2019:
Range of Exercise Prices |  | Outstanding options at December 31, 2019 |  | Weighted- Average Remaining Contractual Life in Years |  | Weighted- Average Exercise Price |  | Exercisable options at December 31, 2019 |  | Weighted- Average Exercise Price
$ | 2.74 | - | $ | 19.59 |  |  | 33,828 |  |  | 8.12 |  | $ | 18.20 |  |  | 33,828 |  | $ | 18.20
$ | 19.66 | - | $ | 19.66 |  |  | 828,891 |  |  | 6.98 |  |  | 19.66 |  |  | 566,036 |  |  | 19.66
$ | 19.96 | - | $ | 23.41 |  |  | 523,812 |  |  | 7.23 |  |  | 22.05 |  |  | 415,233 |  |  | 22.25
$ | 24.66 | - | $ | 120.51 |  |  | 575,001 |  |  | 4.39 |  |  | 56.75 |  |  | 569,938 |  |  | 57.00
|  |  |  |  |  |  | 1,961,532 |  |  | 6.31 |  | $ | 31.16 |  |  | 1,585,035 |  | $ | 33.73
Aggregate intrinsic value (U.S. $ in thousands) | $ | 563 |  |  |  |  |  |  |  | $ | 405 |  |  |
As of December 31, 2019, the weighted-average remaining contractual life of exercisable options was 6.1 years. The total intrinsic value of options exercised during 2019, 2018 and 2017 was approximately $1.0 million, $0.6 million and $7.2 million, respectively. The Company used the Black-Scholes option-pricing model to determine the fair value of options granted during 2018 and 2017. No options were granted during 2019. The following assumptions were applied in determining the options’ fair value on their grant date:
|  | 2018 |  | 2017
Risk-free interest rate |  | 2.9%-3.1% |  | 1.8%-2.2%
Expected option term (years) |  | 5.3-5.5 |  | 5.1-6.0
Expected share price volatility |  | 52.0%-52.2% |  | 52.6%-54.0%
Dividend yield |  |  | — |  |  | —
Weighted average grant date fair value |  | $ | 11.49 |  | $ | 11.10
As of December 31, 2019, the Company had 0.4 million unvested options. As of December 31, 2019, the unrecognized compensation cost related to all unvested, equity-classified stock options of $3.9 million is expected to be recognized as an expense on a straight-line basis over a weighted-average period of 1.2 years. Restricted Stock Units and Performance Stock Units A summary of the Company’s RSUs and PSUs activity for the year ended December 31, 2019 is as follows:
|  | Number of RSUs and PSUs |  | Weighted Average Grant Date Fair Value
Unvested RSUs and PSUs outstanding as of December 31, 2018 |  | 1,422,887 |  |  | $ | 20.17
Granted |  | 1,613,282 |  |  |  | 26.50
Vested |  | (309,642 | ) |  |  | 20.50
Forfeited |  | (363,536 | ) |  |  | 22.32
Unvested RSUs and PSUs outstanding as of December 31, 2019 |  | 2,362,991 |  |  | $ | 24.10
F-33 Table of Contents STRATASYS LTD. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS The total vesting-date value of equity classified RSUs vested during 2019 was $7.4 million. As of December 31, 2019, the unrecognized compensation cost related to all unvested equity classified RSUs and PSUs of $41.6 million is expected to be recognized as an expense on a straight-line basis over a weighted-average period of 2.6 years. Stock-based compensation expense for stock options and equity classified RSUs included in the Company’s Statements of Operations and Comprehensive Loss were allocated as follows:
|  | 2019 |  | 2018 |  | 2017
|  | (U.S. $ in thousands)
Cost of sales |  | $ | 1,848 |  | $ | 1,474 |  | $ | 2,580
Research and development, net |  |  | 5,167 |  |  | 3,215 |  |  | 3,503
Selling, general and administrative |  |  | 13,549 |  |  | 10,997 |  |  | 11,639
Total stock-based compensation expenses |  | $ | 20,564 |  | $ | 15,686 |  | $ | 17,722
c. Accumulated other comprehensive loss The following tables present the changes in the components of accumulated other comprehensive loss, net of taxes for the years ended December 31, 2019, 2018 and 2017:
|  | Year ended December 31, 2019
|  | Net unrealized gain |  | Foreign currency |  |
|  | (loss) on cash flow |  | translation |  |
|  | hedges |  | adjustments |  | Total
|  | U.S. $ in thousands
Balance as of January 1, 2019 |  | $ | (627 | ) |  | $ | (7,126 | ) |  | $ | (7,753 | )
Other comprehensive loss before reclassifications |  |  | 1,548 |  |  |  | (580 | ) |  |  | 968 |
Amounts reclassified from accumulated other comprehensive loss |  |  | (931 | ) |  |  | — |  |  |  | (931 | )
Other comprehensive income (loss) |  |  | 617 |  |  |  | (580 | ) |  |  | 37 |
Balance as of December 31, 2019 |  | $ | (10 | ) |  | $ | (7,706 | ) |  | $ | (7,716 | )
|  | Year ended December 31, 2018
|  | Net unrealized gain |  | Foreign currency |  |
|  | (loss) on cash flow |  | translation |  |
|  | hedges |  | adjustments |  | Total
|  | U.S. $ in thousands
Balance as of January 1, 2018 |  | $ | 330 |  |  | $ | (7,353 | ) |  | $ | (7,023 | )
Other comprehensive loss before reclassifications |  |  | (1,814 | ) |  |  | (2,691 | ) |  |  | (4,505 | )
Amounts reclassified from accumulated other comprehensive loss |  |  | 857 |  |  |  | 2,918 |  |  |  | 3,775 |
Other comprehensive income (loss) |  |  | (957 | ) |  |  | 227 |  |  |  | (730 | )
Balance as of December 31, 2018 |  | $ | (627 | ) |  | $ | (7,126 | ) |  | $ | (7,753 | )
F-34 Table of Contents STRATASYS LTD. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
|  | Year ended December 31, 2017
|  | Net unrealized gain |  | Foreign currency |  |
|  | (loss) on cash flow |  | translation |  |
|  | hedges |  | adjustments |  | Total
|  | U.S. $ in thousands
Balance as of January 1, 2017 |  | $ | (24 | ) |  | $ | (13,455 | ) |  | $ | (13,479 | )
Other comprehensive loss before reclassifications |  |  | 1,315 |  |  |  | 5,834 |  |  |  | 7,149 |
Amounts reclassified from accumulated other comprehensive loss |  |  | (961 | ) |  |  | 268 |  |  |  | (693 | )
Other comprehensive income (loss) |  |  | 354 |  |  |  | 6,102 |  |  |  | 6,456 |
Balance as of December 31, 2017 |  | $ | 330 |  |  | $ | (7,353 | ) |  | $ | (7,023 | )

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration